For: | Wang MQ, Li YP, Xu M, Tian Y, Wu Y, Zhang X, Shi JJ, Dang SS, Jia XL. VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors. World J Gastrointest Oncol 2022; 14(10): 1933-1948 [PMID: 36310697 DOI: 10.4251/wjgo.v14.i10.1933] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v14/i10/1933.htm |
Number | Citing Articles |
1 |
Zhenbang Ye, Ning Huang, Yongliang Fu, Rongle Tian, Liming Wang, Wenting Huang. Tumor purity-related genes for predicting the prognosis and drug sensitivity of DLBCL patients. eLife 2024; 13 doi: 10.7554/eLife.92841.3
|
2 |
Shanqi Li, Yuzhou Qian, Wanchen Xie, Xinyu Li, Jiaying Wei, Long Wang, Guosheng Ren, Xuedong Yin. Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer. Journal of Cancer Research and Clinical Oncology 2024; 150(3) doi: 10.1007/s00432-024-05651-3
|
3 |
Hao Chi, Songyun Zhao, Jinyan Yang, Xinrui Gao, Gaoge Peng, Jinhao Zhang, Xixi Xie, Guobin Song, Ke Xu, Zhijia Xia, Shi Chen, Jinqiu Zhao. T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1137025
|
4 |
Wei Yan, Lin Qiu, Meiling Yang, Anran Xu, Manqi Ma, Qinzi Yuan, Xiaochen Ma, Wenjuan Liang, Xuenong Li, Yanxia Lu. CXCL10 mediates CD8+ T cells to facilitate vessel normalization and improve the efficacy of cetuximab combined with PD-1 checkpoint inhibitors in colorectal cancer. Cancer Letters 2023; 567: 216263 doi: 10.1016/j.canlet.2023.216263
|
5 |
Xinrong Lin, Chuan Tian, Fan Pan, Rui Wang. A novel immune-associated prognostic signature based on the immune cell infiltration analysis for hepatocellular carcinoma. Oncologie 2024; 26(1): 91 doi: 10.1515/oncologie-2023-0360
|